Global Granulocyte Macrophage Colony Stimulating Factor Market Insights, Forecast to 2025

2019-02-11 / 3900.00 / Pharma & Healthcare / 114 Pages

Description

The global Granulocyte Macrophage Colony Stimulating Factor market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Granulocyte Macrophage Colony Stimulating Factor market based on company, product type, end user and key regions.

This report studies the global market size of Granulocyte Macrophage Colony Stimulating Factor in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Granulocyte Macrophage Colony Stimulating Factor in these regions.
This research report categorizes the global Granulocyte Macrophage Colony Stimulating Factor market by top players/brands, region, type and end user. This report also studies the global Granulocyte Macrophage Colony Stimulating Factor market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Aduro BioTech Inc
Amgen Inc
BriaCell Therapeutics Corp
Cold Genesys Inc
GlaxoSmithKline Plc
Humanigen Inc
Mologen AG
Morphotek Inc
Sillajen Biotherapeutics
Takeda Pharmaceutical Co Ltd

Market size by Product
CG-0070
Gimsilumab
GSK-3196165
Lenzilumab
MGN-1601
Others
Market size by End User
Solid Tumor
Lymphoma
Kidney Cancer
Lung Disease
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Granulocyte Macrophage Colony Stimulating Factor market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Granulocyte Macrophage Colony Stimulating Factor market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Granulocyte Macrophage Colony Stimulating Factor companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Granulocyte Macrophage Colony Stimulating Factor submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Granulocyte Macrophage Colony Stimulating Factor are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Granulocyte Macrophage Colony Stimulating Factor market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Content

Table of Contents

1 Study Coverage
1.1 Granulocyte Macrophage Colony Stimulating Factor Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate by Product
1.4.2 CG-0070
1.4.3 Gimsilumab
1.4.4 GSK-3196165
1.4.5 Lenzilumab
1.4.6 MGN-1601
1.4.7 Others
1.5 Market by End User
1.5.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate by End User
1.5.2 Solid Tumor
1.5.3 Lymphoma
1.5.4 Kidney Cancer
1.5.5 Lung Disease
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size
2.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Revenue 2014-2025
2.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales 2014-2025
2.2 Granulocyte Macrophage Colony Stimulating Factor Growth Rate by Regions
2.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales by Regions
2.2.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Granulocyte Macrophage Colony Stimulating Factor Sales by Manufacturers
3.1.1 Granulocyte Macrophage Colony Stimulating Factor Sales by Manufacturers
3.1.2 Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Manufacturers
3.1.3 Global Granulocyte Macrophage Colony Stimulating Factor Market Concentration Ratio (CR5 and HHI)
3.2 Granulocyte Macrophage Colony Stimulating Factor Revenue by Manufacturers
3.2.1 Granulocyte Macrophage Colony Stimulating Factor Revenue by Manufacturers (2014-2019)
3.2.2 Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Manufacturers (2014-2019)
3.3 Granulocyte Macrophage Colony Stimulating Factor Price by Manufacturers
3.4 Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base Distribution, Product Types
3.4.1 Granulocyte Macrophage Colony Stimulating Factor Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Granulocyte Macrophage Colony Stimulating Factor Product Type
3.4.3 Date of International Manufacturers Enter into Granulocyte Macrophage Colony Stimulating Factor Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales by Product
4.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Product
4.3 Granulocyte Macrophage Colony Stimulating Factor Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Granulocyte Macrophage Colony Stimulating Factor Breakdown Data by End User

6 North America
6.1 North America Granulocyte Macrophage Colony Stimulating Factor by Countries
6.1.1 North America Granulocyte Macrophage Colony Stimulating Factor Sales by Countries
6.1.2 North America Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Granulocyte Macrophage Colony Stimulating Factor by Product
6.3 North America Granulocyte Macrophage Colony Stimulating Factor by End User

7 Europe
7.1 Europe Granulocyte Macrophage Colony Stimulating Factor by Countries
7.1.1 Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Countries
7.1.2 Europe Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Granulocyte Macrophage Colony Stimulating Factor by Product
7.3 Europe Granulocyte Macrophage Colony Stimulating Factor by End User

8 Asia Pacific
8.1 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor by Countries
8.1.1 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Countries
8.1.2 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor by Product
8.3 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor by End User

9 Central & South America
9.1 Central & South America Granulocyte Macrophage Colony Stimulating Factor by Countries
9.1.1 Central & South America Granulocyte Macrophage Colony Stimulating Factor Sales by Countries
9.1.2 Central & South America Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Granulocyte Macrophage Colony Stimulating Factor by Product
9.3 Central & South America Granulocyte Macrophage Colony Stimulating Factor by End User

10 Middle East and Africa
10.1 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor by Countries
10.1.1 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Countries
10.1.2 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor by Product
10.3 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor by End User

11 Company Profiles
11.1 Aduro BioTech Inc
11.1.1 Aduro BioTech Inc Company Details
11.1.2 Company Business Overview
11.1.3 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Products Offered
11.1.5 Aduro BioTech Inc Recent Development
11.2 Amgen Inc
11.2.1 Amgen Inc Company Details
11.2.2 Company Business Overview
11.2.3 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Products Offered
11.2.5 Amgen Inc Recent Development
11.3 BriaCell Therapeutics Corp
11.3.1 BriaCell Therapeutics Corp Company Details
11.3.2 Company Business Overview
11.3.3 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2014-2019)
11.3.4 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Products Offered
11.3.5 BriaCell Therapeutics Corp Recent Development
11.4 Cold Genesys Inc
11.4.1 Cold Genesys Inc Company Details
11.4.2 Company Business Overview
11.4.3 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Products Offered
11.4.5 Cold Genesys Inc Recent Development
11.5 GlaxoSmithKline Plc
11.5.1 GlaxoSmithKline Plc Company Details
11.5.2 Company Business Overview
11.5.3 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2014-2019)
11.5.4 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Products Offered
11.5.5 GlaxoSmithKline Plc Recent Development
11.6 Humanigen Inc
11.6.1 Humanigen Inc Company Details
11.6.2 Company Business Overview
11.6.3 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Products Offered
11.6.5 Humanigen Inc Recent Development
11.7 Mologen AG
11.7.1 Mologen AG Company Details
11.7.2 Company Business Overview
11.7.3 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Products Offered
11.7.5 Mologen AG Recent Development
11.8 Morphotek Inc
11.8.1 Morphotek Inc Company Details
11.8.2 Company Business Overview
11.8.3 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Products Offered
11.8.5 Morphotek Inc Recent Development
11.9 Sillajen Biotherapeutics
11.9.1 Sillajen Biotherapeutics Company Details
11.9.2 Company Business Overview
11.9.3 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Products Offered
11.9.5 Sillajen Biotherapeutics Recent Development
11.10 Takeda Pharmaceutical Co Ltd
11.10.1 Takeda Pharmaceutical Co Ltd Company Details
11.10.2 Company Business Overview
11.10.3 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Products Offered
11.10.5 Takeda Pharmaceutical Co Ltd Recent Development

12 Future Forecast
12.1 Granulocyte Macrophage Colony Stimulating Factor Market Forecast by Regions
12.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Regions 2019-2025
12.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Regions 2019-2025
12.2 Granulocyte Macrophage Colony Stimulating Factor Market Forecast by Product
12.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Product 2019-2025
12.2.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Product 2019-2025
12.3 Granulocyte Macrophage Colony Stimulating Factor Market Forecast by End User
12.4 North America Granulocyte Macrophage Colony Stimulating Factor Forecast
12.5 Europe Granulocyte Macrophage Colony Stimulating Factor Forecast
12.6 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Forecast
12.7 Central & South America Granulocyte Macrophage Colony Stimulating Factor Forecast
12.8 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Granulocyte Macrophage Colony Stimulating Factor Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer


Table of Figures

List of Tables and Figures

Figure Granulocyte Macrophage Colony Stimulating Factor Product Picture
Table Granulocyte Macrophage Colony Stimulating Factor Market Segments
Table Key Manufacturers Granulocyte Macrophage Colony Stimulating Factor Covered
Table Global Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate by Product 2019-2025 (K Pcs) & (Million US$)
Figure Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Product 2014-2025
Figure CG-0070 Product Picture
Table Major Manufacturers of CG-0070
Figure Gimsilumab Product Picture
Table Major Manufacturers of Gimsilumab
Figure GSK-3196165 Product Picture
Table Major Manufacturers of GSK-3196165
Figure Lenzilumab Product Picture
Table Major Manufacturers of Lenzilumab
Figure MGN-1601 Product Picture
Table Major Manufacturers of MGN-1601
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Granulocyte Macrophage Colony Stimulating Factor Market Size Growth Rate by End User 2019-2025 (K Pcs)
Figure Solid Tumor
Figure Lymphoma
Figure Kidney Cancer
Figure Lung Disease
Figure Others
Figure Granulocyte Macrophage Colony Stimulating Factor Report Years Considered
Figure Global Granulocyte Macrophage Colony Stimulating Factor Market Size 2014-2025 (Million US$)
Figure Global Granulocyte Macrophage Colony Stimulating Factor Sales 2014-2025 (K Pcs)
Table Global Granulocyte Macrophage Colony Stimulating Factor Market Size by Regions 2014-2019 (K Pcs) & (Million US$)
Table Global Granulocyte Macrophage Colony Stimulating Factor Sales by Regions 2014-2019 (K Pcs)
Table Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Regions 2014-2019
Figure Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Regions 2014-2019
Figure 2018 Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Regions
Table Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Regions 2014-2019 (Million US$)
Table Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Regions 2014-2019
Figure Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Regions 2014-2019
Figure 2018 Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Regions
Table Global Granulocyte Macrophage Colony Stimulating Factor Sales by Manufacturers (2014-2019) (K Pcs)
Table Global Granulocyte Macrophage Colony Stimulating Factor Sales Share by Manufacturers (2014-2019)
Figure Global Granulocyte Macrophage Colony Stimulating Factor Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Granulocyte Macrophage Colony Stimulating Factor Revenue by Manufacturers (2014-2019) (Million USD)
Table Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Manufacturers (2014-2019)
Figure Granulocyte Macrophage Colony Stimulating Factor Value Share by Manufacturers in 2018
Table Key Manufacturers Granulocyte Macrophage Colony Stimulating Factor Price (2014-2019) (USD/Pcs)
Table Granulocyte Macrophage Colony Stimulating Factor Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Granulocyte Macrophage Colony Stimulating Factor Product Type
Table Date of International Manufacturers Enter into Granulocyte Macrophage Colony Stimulating Factor Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Granulocyte Macrophage Colony Stimulating Factor Sales by Product (2014-2019) (K Pcs)
Table Global Granulocyte Macrophage Colony Stimulating Factor Sales Share by Product (2014-2019)
Figure Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Product (2014-2019)
Figure Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Product in 2018
Table Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Product (2014-2019) (Million US$)
Table Global Granulocyte Macrophage Colony Stimulating Factor Revenue Share by Product (2014-2019)
Figure Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Product (2014-2019)
Figure Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Product in 2018
Table Granulocyte Macrophage Colony Stimulating Factor Price by Product 2014-2019 (USD/Pcs)
Table Global Granulocyte Macrophage Colony Stimulating Factor Sales by End User (2014-2019) (K Pcs)
Table Global Granulocyte Macrophage Colony Stimulating Factor Sales Share by End User (2014-2019)
Figure Global Sales Granulocyte Macrophage Colony Stimulating Factor Market Share by End User (2014-2019)
Figure Global Sales Granulocyte Macrophage Colony Stimulating Factor Market Share by End User in 2018
Figure North America Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate 2014-2019 (K Pcs)
Figure North America Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate 2014-2019 (Million US$)
Table North America Granulocyte Macrophage Colony Stimulating Factor Sales by Countries (2014-2019) (K Pcs)
Table North America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries (2014-2019)
Figure 2018 North America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries
Table North America Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries (2014-2019) (Million US$)
Table North America Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries
Figure United States Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2014-2019) (K Pcs)
Figure United States Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2014-2019) (K Pcs)
Figure Canada Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2014-2019) (K Pcs)
Figure Canada Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2014-2019) (K Pcs)
Figure Mexico Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2014-2019) (Million US$)
Table North America Granulocyte Macrophage Colony Stimulating Factor Sales by Product (2014-2019) (K Pcs)
Table North America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Product (2014-2019)
Figure 2018 North America Granulocyte Macrophage Colony Stimulating Factor Market Share by Product
Table North America Granulocyte Macrophage Colony Stimulating Factor Sales by End User (2014-2019) (K Pcs)
Table North America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by End User (2014-2019)
Figure 2018 North America Granulocyte Macrophage Colony Stimulating Factor Market Share by End User
Figure Europe Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate 2014-2019 (K Pcs)
Figure Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Countries (2014-2019) (K Pcs)
Table Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries
Table Europe Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries (2014-2019) (Million US$)
Table Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries
Figure Germany Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2014-2019) (K Pcs)
Figure Germany Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2014-2019) (Million US$)
Figure France Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2014-2019) (K Pcs)
Figure France Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2014-2019) (K Pcs)
Figure UK Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2014-2019) (K Pcs)
Figure Italy Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2014-2019) (K Pcs)
Figure Russia Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Product (2014-2019) (K Pcs)
Table Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Product (2014-2019)
Figure 2018 Europe Granulocyte Macrophage Colony Stimulating Factor Market Share by Product
Table Europe Granulocyte Macrophage Colony Stimulating Factor Sales by End User (2014-2019) (K Pcs)
Table Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by End User (2014-2019)
Figure 2018 Europe Granulocyte Macrophage Colony Stimulating Factor Market Share by End User
Figure Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate 2014-2019 (K Pcs)
Figure Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Countries (2014-2019) (K Pcs)
Table Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries
Table Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries
Figure China Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2014-2019) (K Pcs)
Figure China Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2014-2019) (K Pcs)
Figure Japan Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2014-2019) (K Pcs)
Figure Korea Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2014-2019) (Million US$)
Figure India Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2014-2019) (K Pcs)
Figure India Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2014-2019) (K Pcs)
Figure Australia Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2014-2019) (K Pcs)
Figure Indonesia Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2014-2019) (K Pcs)
Figure Malaysia Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2014-2019) (K Pcs)
Figure Philippines Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2014-2019) (K Pcs)
Figure Thailand Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2014-2019) (K Pcs)
Figure Vietnam Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2014-2019) (K Pcs)
Figure Singapore Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by Product (2014-2019) (K Pcs)
Table Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Market Share by Product
Table Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales by End User (2014-2019) (K Pcs)
Table Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Market Share by End User
Figure Central & South America Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate 2014-2019 (K Pcs)
Figure Central & South America Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Granulocyte Macrophage Colony Stimulating Factor Sales by Countries (2014-2019) (K Pcs)
Table Central & South America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries
Table Central & South America Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries
Figure Brazil Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2014-2019) (K Pcs)
Figure Brazil Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2014-2019) (K Pcs)
Figure Argentina Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Granulocyte Macrophage Colony Stimulating Factor Sales by Product (2014-2019) (K Pcs)
Table Central & South America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Granulocyte Macrophage Colony Stimulating Factor Market Share by Product
Table Central & South America Granulocyte Macrophage Colony Stimulating Factor Sales by End User (2014-2019) (K Pcs)
Table Central & South America Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Granulocyte Macrophage Colony Stimulating Factor Market Share by End User
Figure Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate 2014-2019 (K Pcs)
Figure Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Countries (2014-2019) (K Pcs)
Table Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Countries
Table Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Countries
Figure GCC Countries Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2014-2019) (K Pcs)
Figure GCC Countries Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2014-2019) (K Pcs)
Figure Turkey Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2014-2019) (K Pcs)
Figure Egypt Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate (2014-2019) (K Pcs)
Figure South Africa Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Product (2014-2019) (K Pcs)
Table Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Market Share by Product
Table Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales by End User (2014-2019) (K Pcs)
Table Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Market Share by End User
Table Aduro BioTech Inc Company Details
Table Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Aduro BioTech Inc Recent Development

Table Amgen Inc Company Details
Table Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Amgen Inc Recent Development

Table BriaCell Therapeutics Corp Company Details
Table BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table BriaCell Therapeutics Corp Recent Development

Table Cold Genesys Inc Company Details
Table Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Cold Genesys Inc Recent Development

Table GlaxoSmithKline Plc Company Details
Table GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table GlaxoSmithKline Plc Recent Development

Table Humanigen Inc Company Details
Table Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Humanigen Inc Recent Development

Table Mologen AG Company Details
Table Mologen AG Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Mologen AG Recent Development

Table Morphotek Inc Company Details
Table Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Morphotek Inc Recent Development

Table Sillajen Biotherapeutics Company Details
Table Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Sillajen Biotherapeutics Recent Development

Table Takeda Pharmaceutical Co Ltd Company Details
Table Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Takeda Pharmaceutical Co Ltd Recent Development

Table Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Regions 2019-2025 (K Pcs)
Table Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share Forecast by Regions 2019-2025
Table Global Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share Forecast by Regions 2019-2025
Table Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Product 2019-2025 (K Pcs)
Table Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share Forecast by Product 2019-2025
Table Global Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share Forecast by Product 2019-2025
Table Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by End User 2019-2025 (K Pcs)
Table Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share Forecast by End User 2019-2025
Figure North America Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure North America Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Asia Pacific Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Central & South America Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate Forecast (2019-2025) (K Pcs)
Figure Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Granulocyte Macrophage Colony Stimulating Factor Value Chain
Table Granulocyte Macrophage Colony Stimulating Factor Customers List
Table Granulocyte Macrophage Colony Stimulating Factor Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Request Sample

* mark fields are compulsory